marketcaparena

LCTX

Lineage Cell Therapeutics, Inc.

Company overview

Market capitalization
$245.57M
Employees
72
Latest publication
2026-09-29
About Lineage Cell Therapeutics, Inc.

Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, developing cell replacement therapies to treat serious medical conditions in the United States and internationally. The company develops OpRegen, an allogeneic retinal pigment epithelium cell replacement therapy, which is in Phase 2a clinical trial for the treatment of the age-related macular degeneration; and OPC1, an allogeneic oligodendrocyte progenitor cell therapy that is in Phase 1/2a multicenter clinical trial for the treatment of cervical spinal cord injuries. It also offers ReSonance (ANP1), an allogeneic auditory neuron progenitor cell transplant, which is in preclinical development for the treatment of sensorineural hearing loss; and PNC1, an allogeneic photoreceptor cell transplant, which is in preclinical development for the treatment of vision loss due to photoreceptor dysfunction or damage. In addition, the company is developing RND1, a novel hypoimmune induced pluripotent stem cell line for the development of a cell transplant candidate for the potential treatment of an undisclosed indication, as well as engages in the research and development of ILT1, an allogeneic cell transplant for the treatment of Type 1 Diabetes; and LCT-CON, an allogeneic cell transplant, as well as therapeutic products for retinal diseases, neurological diseases, ophthalmology, metabolic, and disorders and oncology. The company has a collaboration agreement with William Demant Invest for the preclinical development of ReSonance (ANP1). It also has a strategic collaboration with Factor Bioscience Inc. for the development of genetically engineered iPSC line for the company to utilize for differentiation into certain cell transplant product candidates. The company was formerly known as BioTime, Inc. and changed its name to Lineage Cell Therapeutics, Inc. in August 2019. Lineage Cell Therapeutics, Inc. was incorporated in 1990 and is headquartered in Carlsbad, California.

Company website

Financial statements

Income Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
Total Revenue1,725,000USD6,608,000USD3,681,000USD2,765,000USD1,502,000USD2,868,000USD3,779,000USD1,408,000USD
Cost Of Revenue188,000USD66,000USD5,000USD39,000USD36,000USD154,000USD38,000USD44,000USD
Gross Profit1,537,000USD6,542,000USD3,676,000USD2,726,000USD1,466,000USD2,714,000USD3,741,000USD1,364,000USD
Research Development4,234,000USD8,238,000USD3,271,000USD3,106,000USD3,114,000USD3,423,000USD3,171,000USD2,868,000USD
Selling General Administrative5,084,000USD4,852,000USD4,191,000USD4,560,000USD4,857,000USD4,401,000USD4,410,000USD4,363,000USD
Total Operating Expenses9,130,000USD13,090,000USD7,462,000USD22,506,000USD7,971,000USD7,824,000USD7,581,000USD7,231,000USD
Operating Income-7,593,000USD-6,548,000USD-3,786,000USD-19,780,000USD-6,505,000USD-5,110,000USD-3,840,000USD-5,867,000USD
Interest Income405,000USD393,000USD366,000USD454,000USD478,000USD393,000USD397,000USD463,000USD
Net Interest Income405,000USD393,000USD366,000USD454,000USD478,000USD393,000USD397,000USD463,000USD
Income Before Tax-4,789,000USD-4,388,000USD-29,752,000USD-30,364,000USD-4,143,000USD-3,250,000USD-3,001,000USD-5,773,000USD
Net Income-4,812,000USD851,000USD-29,781,000USD-30,464,000USD-4,139,000USD-3,273,000USD-3,034,000USD-5,760,000USD
Net Income From Continuing Ops-4,789,000USD892,000USD-29,752,000USD-30,364,000USD-4,143,000USD-3,250,000USD-3,001,000USD-5,773,000USD
Ebit-7,593,000USD-6,548,000USD-29,752,000USD-4,940,000USD-6,505,000USD-5,110,000USD-3,840,000USD-5,867,000USD
Ebitda-7,405,000USD-6,362,000USD-29,574,000USD-4,769,000USD-6,341,000USD-4,959,000USD-3,699,000USD-5,725,000USD
Depreciation And Amortization188,000USD186,000USD178,000USD171,000USD164,000USD151,000USD141,000USD142,000USD
Reconciled Depreciation188,000USD186,000USD178,000USD171,000USD164,000USD151,000USD141,000USD142,000USD
Total Other Income Expense Net2,804,000USD2,160,000USD-25,966,000USD-10,584,000USD2,362,000USD1,860,000USD839,000USD94,000USD
Minority Interest-23,000USD-41,000USD-29,000USD-100,000USD4,000USD-23,000USD-33,000USD13,000USD
Income Tax Expense—-5,280,000USD———10,000USD33,000USD-13,000USD
Unclassified Operating Expenses———14,840,000USD————
Tax Provision—————0USD0USD0USD
Selling And Marketing Expenses———————142,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Income Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
Total Revenue14,556,000USD9,499,000USD8,945,000USD14,703,000USD3,896,000USD773,000USD1,478,000USD1,416,000USD
Cost Of Revenue845,000USD334,000USD671,000USD728,000USD1,426,000USD385,000USD412,000USD302,000USD
Gross Profit13,711,000USD9,165,000USD8,274,000USD13,975,000USD2,470,000USD388,000USD1,066,000USD1,114,000USD
Research Development17,729,000USD12,472,000USD15,705,000USD13,987,000USD33,914,000USD12,317,000USD17,948,000USD20,955,000USD
Selling General Administrative18,460,000USD18,171,000USD17,302,000USD22,508,000USD18,212,000USD15,571,000USD24,031,000USD24,726,000USD
Total Operating Expenses35,490,000USD30,643,000USD33,007,000USD36,495,000USD51,681,000USD26,835,000USD39,942,000USD42,109,000USD
Operating Income-21,779,000USD-21,478,000USD-24,733,000USD-22,520,000USD-49,211,000USD-26,447,000USD-38,876,000USD-41,795,000USD
Interest Income1,691,000USD1,715,000USD1,629,000USD829,000USD2,000USD1,039,000USD17,110,000USD82,531,000USD
Net Interest Income1,691,000USD1,715,000USD1,629,000USD829,000USD2,000USD1,039,000USD1,685,000USD711,000USD
Income Before Tax-68,647,000USD-18,582,000USD-23,282,000USD-25,812,000USD-43,270,000USD-21,924,000USD-19,234,000USD-47,130,000USD
Income Tax Expense-5,114,000USD27,000USD-1,803,000USD541,000USD-4,706,000USD-1,239,000USD-7,407,000USD-346,000USD
Tax Provision-5,280,000USD0USD-1,803,000USD541,000USD-2,242,000USD-1,239,000USD-7,407,000USD-346,000USD
Net Income-63,533,000USD-18,609,000USD-21,486,000USD-26,273,000USD-43,019,000USD-20,649,000USD-11,709,000USD-45,990,000USD
Net Income From Continuing Ops-63,367,000USD-18,582,000USD-21,479,000USD-26,353,000USD-43,270,000USD-20,685,000USD-26,641,000USD-46,784,000USD
Ebit-21,779,000USD-21,478,000USD-24,733,000USD-22,520,000USD-49,211,000USD-26,447,000USD-38,876,000USD-40,995,000USD
Ebitda-21,080,000USD-20,869,000USD-24,041,000USD-21,793,000USD-48,338,000USD-24,408,000USD-35,876,000USD-37,722,000USD
Depreciation And Amortization699,000USD609,000USD692,000USD727,000USD873,000USD2,039,000USD3,000,000USD3,273,000USD
Reconciled Depreciation699,000USD609,000USD692,000USD727,000USD887,000USD2,111,000USD3,129,000USD3,273,000USD
Total Other Income Expense Net-46,868,000USD2,896,000USD1,451,000USD-3,292,000USD5,941,000USD4,523,000USD19,642,000USD-5,335,000USD
Minority Interest-166,000USD-27,000USD-7,000USD-80,000USD-251,000USD-36,000USD-118,000USD-794,000USD
Selling And Marketing Expenses——562,001USD—————
Interest Expense———5,181,000USD2,000USD5,163,000USD1,685,000USD10,872,000USD
Non Operating Income Net Other———-4,121,000USD5,939,000USD4,523,000USD17,957,000USD-6,046,000USD
Net Income Applicable To Common Shares———-26,273,000USD-43,019,000USD-20,649,000USD-11,709,000USD-45,990,000USD
Unclassified Operating Expenses—————-1,053,000USD-2,037,000USD-3,572,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Balance sheet Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
Total Assets109,533,000USD112,584,000USD89,639,000USD90,799,000USD111,753,000USD113,218,000USD96,594,000USD102,802,000USD
Intangible Assets31,700,000USD31,700,000USD31,700,000USD31,700,000USD46,540,000USD46,540,000USD46,540,000USD46,540,000USD
Other Current Assets1,977,000USD1,814,000USD1,647,000USD1,300,000USD1,866,000USD2,554,000USD1,285,000USD1,659,000USD
Total Liab56,838,000USD69,238,000USD68,843,000USD43,687,000USD34,098,000USD36,206,000USD31,800,000USD35,927,000USD
Total Stockholder Equity53,875,000USD44,549,000USD22,040,000USD48,385,000USD79,028,000USD78,381,000USD66,186,000USD68,300,000USD
Other Current Liab5,567,000USD4,840,000USD3,766,000USD2,954,000USD2,983,000USD4,263,000USD2,878,000USD2,630,000USD
Common Stock529,655,999USD515,467,000USD494,175,000USD490,551,000USD489,313,000USD484,722,000USD469,268,000USD467,928,000USD
Capital Stock529,656,000USD515,467,000USD494,175,000USD490,551,000USD489,313,000USD484,722,000USD469,268,000USD467,928,000USD
Retained Earnings-471,810,000USD-466,998,000USD-467,849,000USD-438,068,000USD-407,604,000USD-403,465,000USD-400,192,000USD-397,158,000USD
Good Will10,672,000USD10,672,000USD10,672,000USD10,672,000USD10,672,000USD10,672,000USD10,672,000USD10,672,000USD
Cash35,939,000USD40,791,000USD40,463,000USD42,271,000USD47,886,000USD45,789,000USD27,750,000USD29,622,000USD
Cash And Short Term Investments53,381,000USD55,781,000USD40,486,000USD42,288,000USD47,905,000USD47,805,000USD32,711,000USD38,496,000USD
Total Current Assets56,164,000USD59,157,000USD42,260,000USD43,844,000USD49,984,000USD50,997,000USD34,401,000USD40,390,000USD
Total Current Liabilities8,148,000USD11,367,000USD9,382,000USD10,756,000USD13,089,000USD13,977,000USD13,864,000USD15,275,000USD
Current Deferred Revenue1,716,000USD3,333,000USD3,766,000USD5,257,000USD6,931,000USD7,388,000USD8,250,000USD9,142,000USD
Net Debt-33,545,000USD-38,372,000USD-37,842,000USD-40,117,000USD-45,642,000USD-43,275,000USD-25,000,000USD-26,671,000USD
Short Term Debt865,000USD853,000USD1,066,000USD1,048,000USD1,180,000USD1,152,000USD1,137,000USD1,115,000USD
Short Long Term Debt Total2,394,000USD2,419,000USD2,621,000USD2,154,000USD2,244,000USD2,514,000USD2,750,000USD2,951,000USD
Short Term Investments17,442,000USD14,990,000USD23,000USD17,000USD19,000USD2,016,000USD4,961,000USD8,874,000USD
Net Receivables806,000USD1,562,000USD127,000USD256,000USD213,000USD638,000USD405,000USD235,000USD
Accounts Payable5,567,000USD2,341,000USD4,550,000USD1,497,000USD1,995,000USD1,174,000USD1,599,000USD2,388,000USD
Property Plant Equipment Net4,624,000USD4,697,000USD4,468,000USD4,072,000USD4,053,000USD4,395,000USD4,375,000USD4,602,000USD
Property Plant Equipment Gross10,270,000USD10,381,000USD9,797,000USD9,132,000USD8,521,000USD8,779,000USD8,568,000USD8,638,000USD
Accumulated Other Comprehensive Income-7,942,000USD-3,920,000USD-4,286,000USD-4,098,000USD-2,681,000USD-2,876,000USD-2,890,000USD-2,470,000USD
Common Stock Shares Outstanding261,175,000shares230,116,000shares228,853,000shares228,356,000shares226,054,000shares200,193,000shares188,835,000shares188,813,000shares
Non Current Assets Total53,369,000USD53,427,000USD47,379,000USD46,955,000USD61,769,000USD62,221,000USD62,193,000USD62,412,000USD
Non Current Liabilities Total48,690,000USD57,871,000USD59,461,000USD32,931,000USD21,009,000USD22,229,000USD17,936,000USD20,652,000USD
Non Currrent Assets Other36,000USD558,000USD539,000USD511,000USD504,000USD614,000USD606,000USD598,000USD
Net Working Capital48,016,000USD47,790,000USD32,878,000USD33,088,000USD36,895,000USD37,020,000USD20,537,000USD25,115,000USD
Unclassified Non Current Assets6,337,000USD5,800,000USD——————
Unclassified Current Liabilities-5,567,000USD—-3,766,000USD—————
Unclassified Non Current Liabilities48,690,000USD57,871,000USD59,461,000USD32,931,000USD21,009,000USD22,229,000USD17,936,000USD20,652,000USD
Unclassified Equity-525,684,999USD-515,467,000USD-494,175,000USD-490,551,000USD-489,313,000USD-484,722,000USD-469,268,000USD-467,928,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Balance sheet Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
Total Assets112,584,000USD113,218,000USD101,019,000USD123,664,000USD174,545,000USD107,949,000USD125,478,000USD101,660,000USD
Intangible Assets31,700,000USD46,540,000USD46,562,000USD46,692,000USD46,822,000USD47,032,000USD48,248,000USD3,125,000USD
Other Current Assets1,814,000USD2,554,000USD2,204,000USD1,828,000USD2,351,000USD2,433,000USD2,063,000USD1,898,000USD
Total Liab69,238,000USD36,206,000USD38,996,000USD51,728,000USD83,647,000USD12,822,000USD14,231,000USD9,414,000USD
Total Stockholder Equity44,549,000USD78,381,000USD63,419,000USD73,339,000USD92,221,000USD96,199,000USD112,959,000USD93,840,000USD
Other Current Liab4,840,000USD4,263,000USD4,220,000USD6,215,000USD24,623,000USD3,680,000USD2,799,000USD4,104,000USD
Common Stock515,467,000USD484,722,000USD451,343,000USD440,280,000USD434,529,000USD393,944,000USD387,062,000USD354,270,000USD
Capital Stock515,467,000USD484,722,000USD451,343,000USD440,280,000USD434,529,000USD393,944,000USD387,062,000USD354,270,000USD
Retained Earnings-466,998,000USD-403,465,000USD-384,856,000USD-363,370,000USD-337,097,000USD-294,078,000USD-273,422,000USD-261,856,000USD
Good Will10,672,000USD10,672,000USD10,672,000USD10,672,000USD10,672,000USD10,672,000USD10,672,000USD—
Cash40,791,000USD45,789,000USD35,442,000USD11,355,000USD55,742,000USD32,585,000USD9,497,000USD23,587,000USD
Cash And Short Term Investments55,781,000USD47,805,000USD35,492,000USD57,875,000USD58,358,000USD41,562,000USD30,716,000USD30,741,000USD
Total Current Assets59,157,000USD50,997,000USD38,441,000USD60,000,000USD111,549,000USD43,999,000USD57,519,000USD36,358,000USD
Total Current Liabilities11,367,000USD13,977,000USD17,960,000USD18,981,000USD47,116,000USD7,769,000USD6,494,000USD6,812,000USD
Current Deferred Revenue3,333,000USD7,388,000USD10,808,000USD9,421,000USD18,119,000USD193,000USD45,000USD42,000USD
Net Debt-38,372,000USD-43,275,000USD-32,490,000USD-7,459,000USD-52,940,000USD-28,760,000USD-4,329,000USD-21,322,000USD
Short Term Debt853,000USD1,152,000USD882,000USD952,000USD831,000USD1,285,000USD1,223,000USD307,000USD
Short Long Term Debt Total2,419,000USD2,514,000USD2,952,000USD3,896,000USD2,802,000USD3,825,000USD5,168,000USD2,265,000USD
Short Term Investments14,990,000USD2,016,000USD50,000USD46,520,000USD2,616,000USD8,977,000USD21,219,000USD7,154,000USD
Net Receivables1,562,000USD638,000USD745,000USD297,000USD50,840,000USD4,000USD24,740,000USD3,719,000USD
Accounts Payable2,341,000USD1,174,000USD2,050,000USD2,393,000USD3,543,000USD2,611,000USD2,427,000USD2,359,000USD
Property Plant Equipment Net4,697,000USD4,395,000USD4,767,000USD5,673,000USD4,872,000USD5,630,000USD8,175,000USD5,835,000USD
Property Plant Equipment Gross10,381,000USD8,779,000USD12,005,000USD11,523,000USD10,174,000USD5,630,000USD8,175,000USD5,835,000USD
Accumulated Other Comprehensive Income-3,920,000USD-2,876,000USD-3,068,000USD-3,571,000USD-5,211,000USD-3,667,000USD-681,000USD1,426,000USD
Common Stock Shares Outstanding230,116,000shares200,193,000shares172,663,000shares169,792,000shares164,502,000shares150,044,000shares145,533,000shares126,903,000shares
Non Current Assets Total53,427,000USD62,221,000USD62,578,000USD63,664,000USD62,996,000USD63,950,000USD67,959,000USD65,302,000USD
Non Current Liabilities Total57,871,000USD22,229,000USD21,036,000USD32,747,000USD36,531,000USD5,053,000USD7,737,000USD2,602,000USD
Non Currrent Assets Other558,000USD614,000USD577,000USD627,000USD630,000USD616,000USD764,000USD505,000USD
Net Working Capital47,790,000USD37,020,000USD20,481,000USD41,019,000USD64,433,000USD36,230,000USD51,025,000USD29,546,000USD
Unclassified Non Current Assets5,800,000USD——————-22,609,000USD
Unclassified Non Current Liabilities57,871,000USD22,229,000USD21,036,000USD-29,803,000USD-34,560,000USD-2,513,000USD-3,792,000USD1,558,000USD
Unclassified Equity-515,467,000USD-484,722,000USD-451,343,000USD-440,280,000USD-434,529,000USD-393,944,000USD-387,062,000USD-354,270,000USD
Deferred Long Term Liab———29,801,000USD34,530,000USD2,076,000USD3,515,000USD—
Other Liab———29,803,000USD34,560,000USD2,513,000USD3,792,000USD644,000USD
Other Assets———627,000USD630,000USD616,000USD864,000USD22,609,000USD
Inventory———1USD——1USD1USD
Non Current Liabilities Other———2,946,000USD2,001,000USD2,977,000USD4,222,000USD400,000USD
Net Tangible Assets———15,975,000USD34,727,000USD38,495,000USD54,039,000USD90,715,000USD
Short Long Term Debt—————523,000USD—70,000USD
Long Term Investments——————0USD55,837,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
Net Income-4,812,000USD951,000USD-29,781,000USD-30,364,000USD-4,143,000USD-3,273,000USD-3,034,000USD-5,760,000USD
Depreciation188,000USD186,000USD178,000USD171,000USD164,000USD151,000USD141,000USD142,000USD
Stock Based Compensation1,172,000USD1,098,000USD1,199,000USD1,238,000USD1,217,000USD1,315,000USD1,330,000USD1,269,000USD
Other Non Cash Items-1,335,999USD-1,916,000USD26,051,000USD25,768,000USD-1,856,000USD-1,522,000USD-6,261,000USD281,000USD
Change To Account Receivables154,000USD-827,000USD130,000USD-43,000USD424,000USD-233,000USD-329,000USD-160,000USD
Change In Working Capital-2,118,000USD83,000USD-64,000USD-2,352,000USD-268,000USD-3,017,000USD2,037,000USD-1,108,000USD
Total Cash From Operating Activities-8,077,999USD-4,878,000USD-3,616,000USD-5,539,000USD-4,886,000USD-6,346,000USD-5,787,000USD-5,176,000USD
Capital Expenditures-55,000USD-111,000USD-12,000USD-14,000USD-97,000USD-365,000USD-88,000USD-50,000USD
Free Cash Flow-8,132,999USD-4,989,000USD-3,628,000USD-5,553,000USD-4,983,000USD-6,711,000USD-5,699,000USD-5,226,000USD
Investments-2,271,000USD-14,935,000USD-12,000USD-14,000USD1,903,000USD2,635,000USD3,888,000USD-8,793,000USD
Total Cashflows From Investing Activities-2,326,000USD-15,334,000USD-12,000USD-14,000USD1,903,000USD2,635,000USD3,888,000USD-8,793,000USD
Net Borrowings-14,000USD-15,000USD-16,000USD-14,000USD-14,000USD-14,000USD-13,000USD—
Total Cash From Financing Activities5,561,000USD20,379,000USD1,834,000USD-307,000USD5,044,000USD21,734,000USD-3,000USD105,000USD
Sale Purchase Of Stock-40,000USD-1,000USD0USD0USD-15,000USD0USD23,000USD0USD
Issuance Of Capital Stock0USD19,632,000USD1,276,000USD-65,000USD5,297,000USD21,806,000USD113,000USD33,000USD
Change In Cash-4,852,000USD347,000USD-1,798,000USD-5,567,000USD1,988,000USD18,048,000USD-1,864,000USD-13,952,000USD
Begin Period Cash Flow40,791,000USD40,977,000USD42,775,000USD48,342,000USD46,354,000USD28,306,000USD30,170,000USD44,122,000USD
End Period Cash Flow35,939,000USD41,324,000USD40,977,000USD42,775,000USD48,342,000USD46,354,000USD28,306,000USD30,170,000USD
Other Cashflows From Investing Activities-55,000USD-288,000USD-123,000USD-14,000USD-97,000USD—-200,000USD—
Other Cashflows From Financing Activities-40,000USD-1,000USD1,850,000USD-228,000USD-224,000USD-58,000USD10,000USD86,000USD
Unclassified Operating Cash Flow-1,172,000USD-5,280,000USD-1,199,000USD—————
Unclassified Financing Cash Flow5,655,000USD20,396,000USD——5,297,000USD21,806,000USD——
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
Net Income-63,533,000USD-18,609,000USD-21,486,000USD-26,353,000USD-43,270,000USD-20,685,000USD-11,827,000USD-46,784,000USD
Depreciation699,000USD609,000USD692,000USD727,000USD873,000USD2,039,000USD3,000,000USD3,273,000USD
Stock Based Compensation4,752,000USD5,077,000USD4,640,000USD4,287,000USD3,519,000USD2,227,000USD3,580,000USD5,402,000USD
Other Non Cash Items48,553,000USD-1,403,000USD195,000USD3,729,000USD202,000USD-3,468,000USD-17,337,000USD6,935,000USD
Change To Account Receivables-316,000USD106,000USD-446,000USD50,314,000USD-857,000USD287,000USD467,000USD46,000USD
Change In Working Capital-4,110,000USD-8,766,000USD-10,804,000USD18,669,000USD21,110,000USD1,373,000USD-1,956,000USD638,000USD
Total Cash From Operating Activities-18,919,000USD-23,092,000USD-28,566,000USD1,059,000USD-23,561,000USD-19,753,000USD-31,947,000USD-30,882,000USD
Capital Expenditures-522,000USD-565,000USD-674,000USD-413,000USD-354,000USD-64,000USD-440,000USD-3,287,000USD
Free Cash Flow-19,441,000USD-23,657,000USD-29,240,000USD646,000USD-23,915,000USD-19,817,000USD-32,387,000USD-34,169,000USD
Investments-12,935,000USD-2,308,000USD46,449,000USD-45,746,000USD9,745,000USD13,038,000USD16,957,000USD3,215,000USD
Total Cashflows From Investing Activities-13,457,000USD-2,308,000USD46,449,000USD-46,159,000USD9,745,000USD13,038,000USD16,957,000USD11,816,000USD
Net Borrowings-59,000USD-54,000USD-54,000USD-32,000USD-20,000USD24,624,000USD-70,000USD-349,000USD
Total Cash From Financing Activities26,950,000USD35,857,000USD6,423,000USD1,632,000USD36,930,000USD29,865,000USD617,000USD5,774,000USD
Sale Purchase Of Stock-16,000USD-23,000USD-37,000USD-17,000USD-54,000USD-27,000USD-110,000USD-241,000USD
Issuance Of Capital Stock26,140,000USD35,876,000USD6,625,000USD148,000USD30,865,000USD5,127,000USD103,000USD6,000,000USD
Change In Cash-5,030,000USD10,362,000USD24,056,000USD-44,341,000USD23,094,000USD23,087,000USD-14,303,000USD-13,286,000USD
Begin Period Cash Flow46,354,000USD35,992,000USD11,936,000USD56,277,000USD33,183,000USD10,096,000USD24,399,000USD37,685,000USD
End Period Cash Flow41,324,000USD46,354,000USD35,992,000USD11,936,000USD56,277,000USD33,183,000USD10,096,000USD24,399,000USD
Other Cashflows From Investing Activities-522,000USD-565,000USD—-45,746,000USD10,099,000USD13,102,000USD17,397,000USD-8,000USD
Other Cashflows From Financing Activities-16,000USD58,000USD-111,000USD1,533,000USD13,379,000USD49,938,000USD764,000USD35,773,000USD
Unclassified Operating Cash Flow-5,280,000USD—-1,803,000USD—-5,995,000USD-1,239,000USD-7,407,000USD—
Unclassified Financing Cash Flow27,041,000USD35,876,000USD6,662,000USD—30,865,000USD-19,523,000USD—5,000,000USD
Unclassified Investing Cash Flow—1,130,000USD—45,746,000USD-9,745,000USD-13,038,000USD-16,957,000USD11,896,000USD
Dividends Paid——-37,000USD—-7,240,000USD-25,147,000USD-40,000USD-34,409,000USD
Change To Liabilities———-18,702,000USD21,645,000USD308,000USD-2,885,000USD1,100,000USD
Cash And Cash Equivalents Changes———-43,468,000USD23,114,000USD23,150,000USD-14,373,000USD-13,292,000USD
Change To Inventory————-72,000USD-308,000USD2,885,000USD122,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Operating metrics

No operating metrics are currently published for this company.

Revenue breakdown

PeriodDimensionBusiness / regionRevenueCurrencySource
Q1 2026Quarterly · 2026-03-31ProductCollaboration Revenues1,575,000USD0001193125-26-219479
Q1 2026Quarterly · 2026-03-31ProductRoyalties License And Other Revenues150,000USD0001193125-26-219479
Q4 2025Quarterly · 2025-12-31ProductCollaboration Revenues6,263,000USDLegacy provider
Q4 2025Quarterly · 2025-12-31ProductRoyalties License And Other Revenues345,000USDLegacy provider
FY 2025Yearly · 2025-12-31ProductCollaboration Revenues13,609,000USD0001193125-26-093992
FY 2025Yearly · 2025-12-31ProductRoyalties License And Other Revenues947,000USD0001193125-26-093992
Q3 2025Quarterly · 2025-09-30ProductCollaboration Revenues3,544,000USD0001193125-25-269599
Q3 2025Quarterly · 2025-09-30ProductRoyalties License And Other Revenues137,000USD0001193125-25-269599
Q2 2025Quarterly · 2025-06-30ProductCollaboration Revenues2,532,000USD0000950170-25-107333
Q2 2025Quarterly · 2025-06-30ProductRoyalties License And Other Revenues233,000USD0000950170-25-107333
Q1 2025Quarterly · 2025-03-31ProductCollaboration Revenues1,270,000USD0001193125-26-219479
Q1 2025Quarterly · 2025-03-31ProductRoyalties License And Other Revenues232,000USD0001193125-26-219479
Q4 2024Quarterly · 2024-12-31ProductCollaboration Revenues2,478,000USDLegacy provider
Q4 2024Quarterly · 2024-12-31ProductRoyalties License And Other Revenues390,000USDLegacy provider
FY 2024Yearly · 2024-12-31ProductCollaboration Revenues8,149,000USD0001193125-26-093992
FY 2024Yearly · 2024-12-31ProductRoyalties License And Other Revenues1,350,000USD0001193125-26-093992
Q3 2024Quarterly · 2024-09-30ProductCollaboration Revenues3,386,000USD0001193125-25-269599
Q3 2024Quarterly · 2024-09-30ProductRoyalties License And Other Revenues393,000USD0001193125-25-269599
Q2 2024Quarterly · 2024-06-30ProductCollaboration Revenues1,098,000USD0000950170-25-107333
Q2 2024Quarterly · 2024-06-30ProductRoyalties License And Other Revenues310,000USD0000950170-25-107333
FY 2023Yearly · 2023-12-31ProductCollaboration Revenues7,588,000USD0000950170-25-036309
FY 2023Yearly · 2023-12-31ProductRoyalties License And Other Revenues1,357,000USD0000950170-25-036309
FY 2022Yearly · 2022-12-31ProductCollaboration Revenues13,367,000USD0001493152-23-007129
FY 2022Yearly · 2022-12-31ProductRoyalties1,336,000USD0001493152-23-007129
FY 2021Yearly · 2021-12-31ProductCollaboration Revenues1,120,000USD0001493152-23-007129
FY 2021Yearly · 2021-12-31ProductGrant Revenues445,000USD0001493152-23-007129
FY 2021Yearly · 2021-12-31ProductRoyalties2,776,000USD0001493152-23-007129
FY 2021Yearly · 2021-12-31GeographyForeign446,000USD0001493152-23-007129
FY 2021Yearly · 2021-12-31GeographyUnited States3,895,000USD0001493152-23-007129
FY 2020Yearly · 2020-12-31ProductGrant Revenues1,053,000USD0001493152-22-006520
FY 2020Yearly · 2020-12-31ProductRoyalties773,000USD0001493152-22-006520
FY 2020Yearly · 2020-12-31GeographyForeign666,000USD0001493152-22-006520
FY 2020Yearly · 2020-12-31GeographyUnited States1,160,000USD0001493152-22-006520
FY 2019Yearly · 2019-12-31ProductGrant2,037,000USD0001493152-21-005814
FY 2019Yearly · 2019-12-31ProductRoyalties From Product Sales And License Fees1,221,000USD0001493152-21-005814
FY 2019Yearly · 2019-12-31ProductSale Of Research Products And Services257,000USD0001493152-21-005814
FY 2019Yearly · 2019-12-31GeographyForeign1,423,000USD0001493152-21-005814
FY 2019Yearly · 2019-12-31GeographyUnited States2,092,000USD0001493152-21-005814
FY 2018Yearly · 2018-12-31ProductGrant3,572,000USD0001493152-20-003818
FY 2018Yearly · 2018-12-31ProductRoyalties From Product Sales And License Fees392,000USD0001493152-20-003818
FY 2018Yearly · 2018-12-31ProductSale Of Research Products And Services333,000USD0001493152-20-003818
FY 2018Yearly · 2018-12-31ProductSubscription And Advertisement691,000USD0001493152-20-003818
FY 2018Yearly · 2018-12-31GeographyForeign3,184,000USD0001493152-20-003818
FY 2018Yearly · 2018-12-31GeographyUnited States1,804,000USD0001493152-20-003818
Q3 2018Quarterly · 2018-09-30GeographyForeign579,000USD0001493152-18-015428
Q3 2018Quarterly · 2018-09-30GeographyUnited States403,000USD0001493152-18-015428
Q2 2018Quarterly · 2018-06-30GeographyForeign1,916,000USD0001493152-18-010859
Q2 2018Quarterly · 2018-06-30GeographyUnited States631,000USD0001493152-18-010859
Q1 2018Quarterly · 2018-03-31GeographyForeign194,000USD0001493152-18-006559
Q1 2018Quarterly · 2018-03-31GeographyUnited States507,000USD0001493152-18-006559
FY 2017Yearly · 2017-12-31GeographyForeign1,807,000USD0001493152-19-003335
FY 2017Yearly · 2017-12-31GeographyUnited States1,651,000USD0001493152-19-003335
Q3 2017Quarterly · 2017-09-30GeographyForeign1,479,000USD0001493152-18-015428
Q3 2017Quarterly · 2017-09-30GeographyUnited States209,000USD0001493152-18-015428
Q2 2017Quarterly · 2017-06-30GeographyForeign194,000USD0001493152-18-010859
Q2 2017Quarterly · 2017-06-30GeographyUnited States187,000USD0001493152-18-010859
Q1 2017Quarterly · 2017-03-31GeographyForeign217,000USD0001493152-18-006559
Q1 2017Quarterly · 2017-03-31GeographyUnited States173,000USD0001493152-18-006559
FY 2016Yearly · 2016-12-31GeographyForeign1,426,000USD0001493152-18-003416
FY 2016Yearly · 2016-12-31GeographyUnited States4,497,000USD0001493152-18-003416
FY 2015Yearly · 2015-12-31GeographyForeign1,060,000USD0001493152-18-003416
FY 2015Yearly · 2015-12-31GeographyUnited States5,976,000USD0001493152-18-003416
FY 2014Yearly · 2014-12-31GeographyAsia1,658,000USD0001140361-17-012402
FY 2014Yearly · 2014-12-31GeographyDomestic3,586,000USD0001140361-17-012402

Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.